Startups
A minimally invasive technique using a balloon catheter to temporarily occlude large vessels in support of hemorrhage control.
Hemorrhage leads to cardiovascular collapse and death unless blood flow to the heart muscle and brain is maintained. For patients with truncal hemorrhage, resuscitative aortic occlusion helps maintain blood flow to these critical organs until the hemorrhage can be definitively controlled via surgery.
Until REBOA, resuscitative aortic occlusion required an invasive surgical procedure which resulted in high mortality and significant resource usage.
Hemorrhage leads to cardiovascular collapse and death unless blood flow to the heart muscle and brain is maintained. For patients with truncal hemorrhage, resuscitative aortic occlusion helps maintain blood flow to these critical organs until the hemorrhage can be definitively controlled via surgery.
Until REBOA, resuscitative aortic occlusion required an invasive surgical procedure which resulted in high mortality and significant resource usage.
Overview
Location
United States, Texas, Boerne
Employees
11-50
Phone
+1 210-340-0116
Total raised
$6M
Founded date
2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 22, 2023 | Prytime Medical Announces Appointment of Robert A. Cohen, M.D., to its Clinical Advisory Board | Dr. Robert A Cohen joins Prytime Medical's Clinical Advisory Board Renowned OB/GYN, Robert A. Cohen, appointed to Prytime Medical's Clinical Advisory Board to advise on Placenta Accreta Spectrum (PAS) medicine SAN ANTONIO, Nov. 22, 2023 /PR... |
| Mar 16, 2023 | Prytime Medical Announces the Launch of the PROMPT Observational Clinical Trial, the first prospective in-human study of Partial REBOA | pREBOA-PRO Catheter. Designed for True Partial REBOA The PROMPT Study will give the trauma community the most compelling data yet on where Partial REBOA using pREBOA-PRO will fit in their toolkit to improve patient outcomes and save lives. ... |
| Nov 8, 2022 | Prytime Medical Announces Appointment of New Chief Medical Officer | Dr. Jeffrey H Lawson The addition of a seasoned medical, surgical and device expert like Dr. Lawson will boost our ability to support physicians whose patients need hemorrhage control and resuscitation. SAN ANTONIO (PRWEB) November 08, 2022... |
| Jun 2, 2021 | Prytime Medical Closes Oversubscribed $6M Inside Funding Round to Fuel Commercialization Growth | |
| Jun 2, 2021 | Prytime Medical Closes $6M Financing | Prytime Medical, Inc., a San Antonio, TX-based provider of life saving REBOA products for truncal hemorrhage control. closed a $6m inside financing. The company intends to use the funds for the commercialization of its innovative new produc... |
| Jan 29, 2013 | Swapping the ER for an e-visit: “Modern-day house call” startup gets $3 million investment | Stat Health Services’ customers are employers and insurance carriers who offer its e-visit service, STAT DOCTORS, to people as a supplement to a health or wellness plan. The company and its network of medical groups provide members with 24/... |
| Swapping the ER for an e-visit: “Modern-day house call” startup gets $3 million investment | More than 136 million Americans visit an emergency room each year, but fewer than 13 percent of them are admitted to the hospital. In fact, a company called Stat Health Services estimates that two of three ER visits are for minor medical co... |
Reviews 0
FAQ about Prytime Medical Devices, Inc.
When was Prytime Medical Devices, Inc. founded?
Prytime Medical Devices, Inc. was founded in 2014.
How much funding has Prytime Medical Devices, Inc. raised?
Prytime Medical Devices, Inc. has raised $6M in total across 1 funding round.
What has the press written about Prytime Medical Devices, Inc.?
Parsers VC has collected 8 articles mentioning Prytime Medical Devices, Inc., among them “Prytime Medical Announces Appointment of Robert A. Cohen, M.D., to its Clinical Advisory Board” (Nov 22, 2023) and “Prytime Medical Announces the Launch of the PROMPT Observational Clinical Trial, the first prospective in-human study of Partial REBOA” (Mar 16, 2023).
Is Prytime Medical Devices, Inc. still active?
Yes, Prytime Medical Devices, Inc. is active; its latest activity on Parsers VC dates from Apr 30, 2024.